356 related articles for article (PubMed ID: 35078421)
1. High complement protein C1q levels in pulmonary fibrosis and non-small cell lung cancer associated with poor prognosis.
Kou W; Li B; Shi Y; Zhao Y; Yu Q; Zhuang J; Xu Y; Peng W
BMC Cancer; 2022 Jan; 22(1):110. PubMed ID: 35078421
[TBL] [Abstract][Full Text] [Related]
2. A low DNA methylation epigenotype in lung squamous cell carcinoma and its association with idiopathic pulmonary fibrosis and poorer prognosis.
Hata A; Nakajima T; Matsusaka K; Fukuyo M; Morimoto J; Yamamoto T; Sakairi Y; Rahmutulla B; Ota S; Wada H; Suzuki H; Matsubara H; Yoshino I; Kaneda A
Int J Cancer; 2020 Jan; 146(2):388-399. PubMed ID: 31241180
[TBL] [Abstract][Full Text] [Related]
3. CAV1 is a prognostic predictor for patients with idiopathic pulmonary fibrosis and lung cancer.
Yin D; Qiu J; Hu S; Cheng L; Li H; Cheng X; Wang S; Lu J
J Biosci; 2022; 47():. PubMed ID: 35092415
[TBL] [Abstract][Full Text] [Related]
4. Shared biomarkers and mechanisms in idiopathic pulmonary fibrosis and non-small cell lung cancer.
Ding X; Liu H; Xu Q; Ji T; Chen R; Liu Z; Dai J
Int Immunopharmacol; 2024 Jun; 134():112162. PubMed ID: 38703565
[TBL] [Abstract][Full Text] [Related]
5. Identification of Hub Genes in Idiopathic Pulmonary Fibrosis and Their Association with Lung Cancer by Bioinformatics Analysis.
Velázquez-Enríquez JM; Reyes-Avendaño I; Santos-Álvarez JC; Reyes-Jiménez E; Vásquez-Garzón VR; Baltiérrez-Hoyos R
Adv Respir Med; 2023 Oct; 91(5):407-431. PubMed ID: 37887075
[TBL] [Abstract][Full Text] [Related]
6. [Identification of SULF1 as a Shared Gene in Idiopathic Pulmonary Fibrosis
and Lung Adenocarcinoma].
Wang J; Lu L; He X; Ma L; Chen T; Li G; Yu H
Zhongguo Fei Ai Za Zhi; 2023 Sep; 26(9):669-683. PubMed ID: 37985153
[TBL] [Abstract][Full Text] [Related]
7. Identification of common signatures in idiopathic pulmonary fibrosis and lung cancer using gene expression modeling.
Leng D; Yi J; Xiang M; Zhao H; Zhang Y
BMC Cancer; 2020 Oct; 20(1):986. PubMed ID: 33046043
[TBL] [Abstract][Full Text] [Related]
8. Identification of diagnostic hub genes related to neutrophils and infiltrating immune cell alterations in idiopathic pulmonary fibrosis.
Lin Y; Lai X; Huang S; Pu L; Zeng Q; Wang Z; Huang W
Front Immunol; 2023; 14():1078055. PubMed ID: 37334348
[TBL] [Abstract][Full Text] [Related]
9. Identification and Validation of Potential Biomarkers and Pathways for Idiopathic Pulmonary Fibrosis by Comprehensive Bioinformatics Analysis.
Qian W; Cai X; Qian Q; Zhang X
Biomed Res Int; 2021; 2021():5545312. PubMed ID: 34285914
[TBL] [Abstract][Full Text] [Related]
10. Expression profiles of Toll-like receptors in non-small cell lung cancer and idiopathic pulmonary fibrosis.
Samara KD; Antoniou KM; Karagiannis K; Margaritopoulos G; Lasithiotaki I; Koutala E; Siafakas NM
Int J Oncol; 2012 May; 40(5):1397-404. PubMed ID: 22344343
[TBL] [Abstract][Full Text] [Related]
11. The Role of TGF-β Signaling in Lung Cancer Associated with Idiopathic Pulmonary Fibrosis.
Saito A; Horie M; Micke P; Nagase T
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30445777
[TBL] [Abstract][Full Text] [Related]
12. S100A12 as Biomarker of Disease Severity and Prognosis in Patients With Idiopathic Pulmonary Fibrosis.
Li Y; He Y; Chen S; Wang Q; Yang Y; Shen D; Ma J; Wen Z; Ning S; Chen H
Front Immunol; 2022; 13():810338. PubMed ID: 35185901
[TBL] [Abstract][Full Text] [Related]
13. Periostin secreted by activated fibroblasts in idiopathic pulmonary fibrosis promotes tumorigenesis of non-small cell lung cancer.
Yamato H; Kimura K; Fukui E; Kanou T; Ose N; Funaki S; Minami M; Shintani Y
Sci Rep; 2021 Oct; 11(1):21114. PubMed ID: 34702952
[TBL] [Abstract][Full Text] [Related]
14. MicroRNAs in non-small cell lung cancer and idiopathic pulmonary fibrosis.
Mizuno K; Mataki H; Seki N; Kumamoto T; Kamikawaji K; Inoue H
J Hum Genet; 2017 Jan; 62(1):57-65. PubMed ID: 27488441
[TBL] [Abstract][Full Text] [Related]
15. [Research Progress on Pathogenic Mechanism and Potential Therapeutic Drugs of
Idiopathic Pulmonary Fibrosis Complicated with Non-small Cell Lung Cancer].
Xiao T; Bao J; Liu X; Huang H; Zhou H
Zhongguo Fei Ai Za Zhi; 2022 Oct; 25(10):756-763. PubMed ID: 36167462
[TBL] [Abstract][Full Text] [Related]
16. Genetic alterations in squamous cell lung cancer associated with idiopathic pulmonary fibrosis.
Hata A; Nakajima T; Matsusaka K; Fukuyo M; Nakayama M; Morimoto J; Ito Y; Yamamoto T; Sakairi Y; Rahmutulla B; Ota S; Wada H; Suzuki H; Iwata T; Matsubara H; Ohara O; Yoshino I; Kaneda A
Int J Cancer; 2021 Jun; 148(12):3008-3018. PubMed ID: 33533494
[TBL] [Abstract][Full Text] [Related]
17. Identification of hub genes associated with COVID-19 and idiopathic pulmonary fibrosis by integrated bioinformatics analysis.
Chen Q; Xia S; Sui H; Shi X; Huang B; Wang T
PLoS One; 2022; 17(1):e0262737. PubMed ID: 35045126
[TBL] [Abstract][Full Text] [Related]
18. Identification of Hub Genes in Idiopathic Pulmonary Fibrosis and NSCLC Progression:Evidence From Bioinformatics Analysis.
Yao Y; Li Z; Gao W
Front Genet; 2022; 13():855789. PubMed ID: 35480306
[No Abstract] [Full Text] [Related]
19. Identification of three hub genes related to the prognosis of idiopathic pulmonary fibrosis using bioinformatics analysis.
Wang E; Wang Y; Zhou S; Xia X; Han R; Fei G; Zeng D; Wang R
Int J Med Sci; 2022; 19(9):1417-1429. PubMed ID: 36035368
[No Abstract] [Full Text] [Related]
20. Modified GAP index for prediction of acute exacerbation of idiopathic pulmonary fibrosis in non-small cell lung cancer.
Kobayashi H; Omori S; Nakashima K; Wakuda K; Ono A; Kenmotsu H; Naito T; Murakami H; Endo M; Takahashi T
Respirology; 2017 Oct; 22(7):1379-1385. PubMed ID: 28543987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]